排序
S2k指南——默克尔细胞癌(MCC,皮肤神经内分泌癌)——2022年更新
角Check for updatesReceived:20 May 2022 Accepted:9 September 2022D0l:10.1111/dd9.14930DDGGUIDELINES2k Guideline-Merkel cell carcinoma(MCC,neuroendocrinecarcinoma of the skin)-Updat...
2023WGO全球指南:益生菌和益生元
World Gastroenterology Organisation Global GuidelinesProbiotics and prebioticsFebruary 2023ORGANISATIONCASCADe5t.1958A Resource Sensitive SolutionReview TeamFrancisco Guarner(Chair...
2023更新—2015NICE指南:糖尿病足问题的预防和管理(NG.19)
NICENational Institute forHealth and Care ExcellenceNICE标贝Public HealthEnglandguidelineDiabetic foot problems:prevention andmanagementNICE guidelinePublished:26 August 2015www.ni...
2023年《甲状腺结节和分化型甲状腺癌诊治指南(第二版)》解读
现代医药卫生202B年4月第39卷第8期J Mod Med Health,April20☒,Vd39,h.8·1261·指南解读·2023年《甲状腺结节和分化型甲状腺癌诊治指南(第二版)》解读*尹经霞',程龙,蒲丹岚2,廖浦△(1.武...
中国成人肥厚型心肌病诊断与治疗指南2023
实用心脑肺血管病杂志2023年3月第31卷第3期投稿网址:htp小www.syxnf.net·73泰安市城市肥胖儿童为例[D]曲阜:曲阜师范大学,2021.parents and children agree on asthma symptoms with exereis...
2023AAP临床实践指南:儿童和青少年肥胖的评估和治疗
CLINICAL PRACTICE GUIDELINE Guidance for the Clinician in Rendering Pediatric CareAmerican Academyof PediatricsDEDICATED TO THE HEALTH OF ALL CHILDRENClinical Practice Guideline fo...
2023NICE技术鉴定指导意见:曲妥珠单抗deruxtecan用于在1次或多次抗HER2治疗后治疗HER2阳性不可切除或转移性乳腺癌[TA862]
NENatonalinsutute forHealth and Care ExcellenceNICE贝guidanceTrastuzumab deruxtecanfor treating HER2-positiveunresectable or metastaticbreast cancer after 1 ormore anti-HER2treatme...
儿童体外膜肺氧合支持治疗的护理专家共识
指南与标准中华急危重症护理杂志2023年3月第4卷第3期儿童体外膜肺氧合支持治疗的护理专家共识浙江大学医学院附属儿童医院护理部首都医科大学附属儿童医院儿科重症监护病房上海复旦大学附属儿科...
子宫内膜癌新进展及指南更新要点
2024 Cancer statistics数据:子宫内膜癌发病率和死亡率明显上升coFnrdatocexeMoru'TyFemaleFemaleBreast.31072012%Lung &bronchus5928021%Lung &brcnches11g27012%Becost42.25015%Colon rectum...
MDS儿科特别工作组基于共识的建议:对患有运动障碍的年轻人的过渡性护理
MovementDisordersREVIEWCLINICAL PRACTICETransitional Care for Young People withMovement Disorders:Consensus-BasedRecommendations from the MDS TaskForce on PediatricsTamara Pringshe...
——2022年更新-af987efe01-pdf-1.webp)

-b3fd7b64ba-pdf-1.webp)
》解读-9036eef4d6-pdf-1.webp)


![2023NICE技术鉴定指导意见:曲妥珠单抗deruxtecan用于在1次或多次抗HER2治疗后治疗HER2阳性不可切除或转移性乳腺癌[TA862]-医知素材库](https://cdn.jiaoyuwz.com/2023NICE技术鉴定指导意见:曲妥珠单抗deruxtecan用于在1次或多次抗HER2治疗后治疗HER2阳性不可切除或转移性乳腺癌[TA862]-816b7b06b5-pdf-1.webp)



